A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes - Niewczas, Monika A.; Pavkov, Meda E.; Skupien, Jan; Smiles, Adam; Md Dom, Zaipul I.; Wilson, Jonathan M.; Park, Jihwan; Nair, Viji; Schlafly, Andrew; Saulnier, Pierre-Jean; Satake, Eiichiro; Simeone, Christopher A.; et al. (Nature medicine, 2019)
Keywords: 692/163/2743/137; 692/308/174; 692/308/53; 692/308/575; 692/699/1585; Adult; Aged; Biological markers; Biomarkers; Biomarkers - blood; Biomedical and Life Sciences; Biomedicine; Blood Proteins - genetics; Blood Proteins - metabolism; Cancer Research; Chronic kidney failure; Cohort Studies; Complications and side effects; Cytokine receptors; Development and progression; Diabetes; Diabetes mellitus; Diabetes mellitus (insulin dependent); Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 1 - blood; Diabetes Mellitus, Type 1 - complications; Diabetes Mellitus, Type 1 - genetics; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - genetics; Diabetic Nephropathies - blood; Diabetic Nephropathies - etiology; Diabetic Nephropathies - genetics; Diabetics; Disease Progression; End-stage renal disease; Female; Health aspects; Humans; Infectious Diseases; Inflammation; Inflammation Mediators - blood; Kidney diseases; Kidney Failure, Chronic - blood; Kidney Failure, Chronic - etiology; Kidney Failure, Chronic - genetics; Kidneys; Male; Medical schools; Metabolic Diseases; Middle Aged; Molecular Medicine; Necrosis; Neurosciences; Prognosis; Prospective Studies; Proteins; Proteomics; Receptors, Tumor Necrosis Factor - blood; Receptors, Tumor Necrosis Factor - genetics; Risk; Risk Factors; Therapeutic applications; Tumor necrosis factor; Tumors; Type 2 diabetes